newsfilter
← Latest News
GlobeNewswire·

BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026

  • BioStem Technologies (NASDAQ: BSEM) will release its third quarter 2026 financial results on Thursday, November 12, 2026.
  • The company will host a conference call & webcast at 4:30 PM ET featuring an overview of the quarter by management.
  • Conference access details include ID 107 437 691, a North America toll-free number, an international toll number, & a specific webcast link.
  • BioStem is a regenerative medicine firm developing, manufacturing, & commercializing perinatal tissue allografts using proprietary BioRetain®, CryoTek®, & SteriTek® technologies.
  • The company's quality systems are accredited by the Association for Advancing Tissue & Biologics (AATB) & comply with cGTP & cGMP standards.
  • BioStem's product portfolio includes the Neox®, Clarix®, VENDAJE®, & American Amnion™ brands.
  • Investor relations inquiries can be directed to Philip Trip Taylor of the Gilmartin Group.